ProfileGDS5678 / 1444635_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 42% 42% 42% 40% 42% 60% 41% 42% 41% 42% 42% 42% 42% 42% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 13.0067842
GSM967853U87-EV human glioblastoma xenograft - Control 22.9658742
GSM967854U87-EV human glioblastoma xenograft - Control 32.9702242
GSM967855U87-EV human glioblastoma xenograft - Control 42.8515640
GSM967856U87-EV human glioblastoma xenograft - Control 52.9123342
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 13.6920960
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 22.9980341
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 32.9500542
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 42.9326241
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 12.958242
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 22.95742
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 32.9495442
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 42.9646242
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 52.9621342